Sign In
Buy ELV
$388.50
-2.77 (-0.708%)
At Close: Jun 18, 2026
Elevance Health: A Quality Underpriced Stock Returning To Health
10:44am, Wednesday, 11'th Dec 2024
Elevance Health has shown robust financial performance, with a 9.1% revenue CAGR and 13.7% EPS growth over the past decade. Despite recent share price weakness, ELV's long-term fundamentals remain str
New Strong Sell Stocks for December 11th
04:50am, Wednesday, 11'th Dec 2024
AVNS, BATRK and ELV have been added to the Zacks Rank #5 (Strong Sell) List on December 11, 2024.
Elevance Health Stock Falls As Anthem Faces Backlash Over Anesthesia Policy, Announces Reversal
12:35pm, Friday, 06'th Dec 2024
When Anthem Blue Cross Blue Shield said it will no longer pay for anesthesia care if the surgery or procedure exceeds an arbitrary time limit, parent company Elevance Health Inc ELV faced backlash and
SAN DIEGO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers violated securi
My Top 15 High-Growth Dividend Stocks For December 2024
06:00am, Monday, 02'nd Dec 2024
The SPDR S&P 500 ETF Trust posted a strong gain of 5.96% in November, resuming its strong run in 2024. The Top 15 dividend growth stocks for December 2024 offer an average dividend yield of 1.2% and a
SAN DIEGO, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers violated securi
Elevance Health, Inc. (ELV) UBS Global Healthcare Conference (Transcript)
02:13pm, Friday, 15'th Nov 2024
Elevance Health, Inc. (NYSE:ELV ) UBS Global Healthcare Conference November 12, 2024 10:15 AM ET Company Participants Mark Kaye - Executive VP & CFO Conference Call Participants A.J. Rice - UBS A.J.
Elevance Health Declines 20% in 3 Months: Time to Sell the Stock?
02:00pm, Tuesday, 12'th Nov 2024
ELV encounters headwinds such as higher benefit costs, an increased debt level and member attrition in the Medicaid business, which raise concerns among investors.
SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Elevance Health, Inc. (NYSE: ELV) or any of its executive officers or others viola
Elevance Health Announces Appearance at UBS Global Healthcare Conference
04:05pm, Tuesday, 05'th Nov 2024
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at the UBS Global Healthcare Conference in Rancho Palos Verdes, California on
My Top 15 High-Growth Dividend Stocks For November 2024
02:44pm, Sunday, 03'rd Nov 2024
The SPDR S&P 500 ETF Trust posted a loss of 0.89% in October, putting a pause on its strong run in 2024. The Top 15 dividend growth stocks for November 2024 offer an average dividend yield of 1.24% an
Elevance Health Foundation Names Professional Football Player Ryan Kelly as Next Elevance Health Champion
09:00am, Tuesday, 29'th Oct 2024
INDIANAPOLIS--(BUSINESS WIRE)-- #maternalhealth--The Elevance Health Foundation, the philanthropic arm of Elevance Health, today announces professional football player Ryan Kelly as its latest Elevanc
AM Best Assigns Issue Credit Ratings to Elevance Health, Inc. New Senior Unsecured Bonds
10:16am, Thursday, 24'th Oct 2024
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to Elevance Health, Inc.'s (Elevance Health) (Indianapolis, IN) newly issued $350 million, 4.5
'Overuse' is causing healthcare insurer headwinds, says Mizuho's Jared Holz
02:41pm, Monday, 21'st Oct 2024
Jared Holz, Mizuho healthcare equity strategist, joins CNBC's 'The Exchange' to discuss why healthcare insurer stocks are down, whether weight loss drugs have any impact, and more.
What's Behind The 15% Fall For Elevance Health Stock?
11:39am, Monday, 21'st Oct 2024
Elevance Health (NYSE: ELV) recently reported its Q3 results, with revenues exceeding but earnings missing the consensus estimates. The company reported revenue of $44.7 billion and adjusted earnings
